February 19, 2026 - Ferrari N.V. (NYSE/EXM: RACE) announced today that it has published its 2025 Annual Report and filed with the United States Securities and Exchange Commission ...
Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ultragenyx Pharmaceutical ...